Swiss Re AG (SSREY) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
P/E 10.09 means the share price is 10.09 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $49.1B is the value of all shares combined. Beta 0.40: the stock has moved about 60% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerSwiss Re AG (SSREY) trades at $41.63 with MoonshotScore 50/100 (Grade B). Swiss Re AG is a leading global reinsurance company, providing a wide array of risk transfer, insurance, and related services. Market cap: $49.1B, Sector: Financial services.
Price as of Sep 11, 2026 · Last analyzed: Mar 15, 2026SSREY stock analysis for 2026: The stored analyst price target for Swiss Re AG is $37.10; its date is unknown, so no upside or downside is derived from it against the current price of $41.63. The AI MoonshotScore is 50/100, in the Fair band (45-64) — a research signal, not a recommendation. Key factors: analyst coverage, AI-driven quantitative scoring.
SSREY: 1/3 scored disciplines lean bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Swiss Re AG (SSREY) Financial Services Profile
Swiss Re AG, a global reinsurance leader founded in 1863, offers comprehensive risk transfer solutions across property, casualty, life, and health sectors. With a $49.1B market cap and a 4.61% dividend yield, Swiss Re serves diverse clients worldwide, maintaining a strong market presence through its diversified reinsurance offerings.
What Is the Investment Thesis for SSREY?
The company's consistent profitability, reflected in a 9.9% profit margin, underscores its ability to navigate the complexities of the reinsurance market. Growth catalysts include increasing demand for reinsurance in emerging markets and the development of innovative risk transfer solutions. However, potential risks include exposure to large-scale catastrophic events and fluctuations in interest rates. With a P/E ratio of 10.09 and a beta of 0.40, Swiss Re offers a blend of value and stability. Investors should monitor the company's performance in managing its risk exposure and capitalizing on growth opportunities in the reinsurance sector.
Based on FMP financials and quantitative analysis
SSREY Key Highlights
Market capitalization of $49.1B reflects Swiss Re's significant presence in the global reinsurance market.
- P/E ratio of 10.09 indicates a reasonable valuation relative to earnings.
- Profit margin of 9.9% demonstrates consistent profitability and operational efficiency.
- Gross margin of 100.0% highlights the nature of the reinsurance business model.
- Dividend yield of 4.61% offers an attractive income stream for investors.
Who Are SSREY's Competitors?
SSREY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ARZGF Assicurazioni Generali S.p.A. | $48.00 | 0.00% | $71.8B | — |
| BHKLY BOC Hong Kong (Holdings) Limited | $132.07 | +0.42% | $69.8B | 579-signal |
| CRARY Crédit Agricole S.A. | $10.66 | -0.09% | $64.5B | — |
| HVRRF Hannover Rück SE | $291.63 | 0.00% | $35.2B | — |
| RGA Reinsurance Group of America, Incorporated | $247.44 | +0.98% | $16.2B | 925-pillar |
| MURGY Münchener Rückversicherungs-Gesellschaft AG in München | $11.56 | +0.70% | $15.1B | 549-signal |
| EG Everest Re Group, Ltd. | $371.03 | +0.86% | $14.7B | 945-pillar |
| RNR RenaissanceRe Holdings Ltd. | $326.53 | +1.24% | $13.6B | 1005-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.
What Are SSREY's Key Strengths?
Global presence and strong brand reputation
- Diversified business model across multiple lines of reinsurance
- Expertise in complex risk management and modeling
- Significant capital base and financial strength
What Are SSREY's Weaknesses?
Exposure to large-scale catastrophic events
- Sensitivity to fluctuations in interest rates
- Complexity of reinsurance contracts and risk modeling
- Dependence on the financial health of its clients
What Could Drive SSREY Stock Higher?
Increasing demand for reinsurance in emerging markets.
- Development of innovative risk transfer solutions for emerging risks.
- Strategic partnerships with insurtech companies to enhance technological capabilities.
- Focus on sustainable and responsible reinsurance practices to attract socially conscious investors.
- Capitalizing on the longevity risk market with reinsurance solutions for pension funds and life insurance companies.
What Are the Key Risks for SSREY?
Financial-distress signal — its Altman Z-Score of 1.80 sits in the distress zone (elevated bankruptcy risk).
- Exposure to large-scale catastrophic events, such as natural disasters and pandemics.
- Sensitivity to fluctuations in interest rates and currency exchange rates.
- Increasing competition from other reinsurance companies.
- Changes in regulatory requirements and capital standards.
- Adverse developments in the global economy.
What Are the Growth Opportunities for SSREY?
- Expansion in Emerging Markets: The increasing insurance penetration in emerging markets presents a significant growth opportunity for Swiss Re. As these economies develop, the demand for reinsurance solutions to protect against various risks, including natural disasters and infrastructure projects, is expected to rise. By establishing a stronger presence in regions like Asia-Pacific and Latin America, Swiss Re can capitalize on this growing demand and diversify its revenue streams. This expansion could contribute to a 5-7% annual revenue growth over the next five years.
- Development of Innovative Risk Transfer Solutions: Swiss Re can drive growth by developing innovative risk transfer solutions tailored to emerging risks such as cyber threats and climate change. These solutions can include parametric insurance products, which provide payouts based on predefined triggers, and catastrophe bonds, which transfer risk to capital markets. By staying at the forefront of innovation, Swiss Re can attract new clients and differentiate itself from competitors. The market for cyber insurance alone is projected to reach $20 billion by 2028.
- Strategic Partnerships with Insurtech Companies: Collaborating with insurtech companies can enable Swiss Re to enhance its technological capabilities and improve its operational efficiency. By leveraging insurtech solutions for data analytics, risk modeling, and claims processing, Swiss Re can gain a competitive edge and offer more personalized and cost-effective reinsurance products. These partnerships can also facilitate the development of new distribution channels and reach a wider customer base. Expect to see efficiency gains of 2-3% annually.
- Focus on Sustainable and Responsible Reinsurance: With increasing emphasis on environmental, social, and governance (ESG) factors, Swiss Re can attract socially conscious investors and clients by focusing on sustainable and responsible reinsurance practices. This can include offering reinsurance solutions for renewable energy projects, promoting sustainable agriculture, and supporting initiatives to mitigate climate change. By integrating ESG considerations into its business strategy, Swiss Re can enhance its reputation and create long-term value.
- Capitalizing on the Longevity Risk Market: As populations age globally, the longevity risk market presents a significant growth opportunity for Swiss Re's Life & Health Reinsurance segment. By offering reinsurance solutions for pension funds and life insurance companies, Swiss Re can help them manage the financial risks associated with increasing life expectancies. This can include developing innovative products that transfer longevity risk to capital markets. The global longevity risk transfer market is estimated to be worth $100 billion.
What Are SSREY's Competitive Advantages?
- Strong brand reputation and global presence
- Expertise in complex risk management and modeling
- Diversified business model across multiple lines of reinsurance
- Significant capital base and financial strength
What Does SSREY Do?
Founded in 1863 in Zurich, Switzerland, Swiss Re AG has evolved into one of the world's foremost reinsurance companies. Initially focused on providing reinsurance for fire risks, the company expanded its offerings over the decades to include a comprehensive suite of risk transfer solutions. Today, Swiss Re operates through three primary segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment provides reinsurance for property, casualty, and specialty lines such as aviation, marine, and cyber risks. The Life & Health Reinsurance segment focuses on life and health insurance products, offering solutions for mortality, morbidity, and longevity risks. The Corporate Solutions segment delivers standard risk transfer covers and customized multi-line programs to corporations. Swiss Re serves a diverse clientele, including stock and mutual insurance companies, public sector entities, large corporations, and individuals. With a global presence, Swiss Re maintains a strong foothold in key markets across Europe, the Americas, and Asia-Pacific, leveraging its expertise and financial strength to provide innovative risk management solutions.
What Products and Services Does SSREY Offer?
- Provides reinsurance solutions to insurance companies worldwide.
- Offers risk transfer covers and multi-line programs to corporations.
- Underwrites property and casualty reinsurance, including coverage for natural disasters and other risks.
- Provides life and health reinsurance products, including solutions for mortality and morbidity risks.
- Offers customized solutions to meet the specific needs of its clients.
- Serves stock and mutual insurance companies, public sector entities, and large corporations.
- Provides risk management expertise and consulting services.
How Does SSREY Make Money?
- Swiss Re generates revenue by underwriting reinsurance contracts and collecting premiums.
- The company invests its capital to generate investment income.
- Swiss Re manages its risk exposure through diversification and risk modeling.
- The company provides value to its clients by transferring risk and providing financial protection.
What Industry Does SSREY Operate In?
Swiss Re AG operates within the global reinsurance industry, which plays a crucial role in mitigating risks for insurance companies and corporations. The industry is characterized by increasing demand for risk transfer solutions, driven by factors such as climate change, urbanization, and technological advancements. The competitive landscape includes major players such as ARZGF (Allianz SE), ARZGY (Allianz SE), BHKLY (Berkshire Hathaway Inc), CRARY (Chubb Limited), and HVRRF (Hannover Rueck SE). Swiss Re distinguishes itself through its diversified business model, global reach, and expertise in complex risk management. The reinsurance market is expected to grow steadily, driven by increasing awareness of risk and the need for financial protection against catastrophic events.
Who Are SSREY's Key Customers?
- Stock and mutual insurance companies
- Public sector and governmental entities
- Mid-sized and large corporations
- Individuals
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 73 days ago
- ● Covered by analysts
Why 50?
This rating comes from our nine-signal model, which produces a score but not a per-factor breakdown. The sector-relative five-pillar model, which explains its own contributions, does not cover this listing yet. How the score is built →
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 50 |
| 2026-08-26 | 50 |
| 2026-08-29 | 50 |
| 2026-09-01 | 50 |
| 2026-09-04 | 50 |
| 2026-09-07 | 50 |
| 2026-09-10 | 50 |
What changed?
The score has stayed at 50.
Over the same 18 days the stock moved -4.4%.
Earnings Track Record
Swiss Re AG has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 171.5% above estimates on average.
Financial Health
Swiss Re AG's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.80 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Swiss Re AG stands at 20.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.7%, showing how much profit it generates from its asset base. SSREY trades at a trailing price-to-earnings ratio of 10.09, below the Financial Services sector average of ~17.50x. Its free cash flow yield is 4.6%, a gauge of the cash the business throws off relative to its market value. Its earnings yield is 10.1%, the inverse of the P/E and a quick read on earnings relative to price.
Swiss Re AG (SSREY) Valuation Context
Valued at $49.1B, SSREY is classified as a large-cap stock. Relative to its peer group, SSREY's quantitative score of 50/100 is below the peer average of 79/100.
SSREY Revenue & Earnings Trend
In Q2 FY2026, SSREY generated $22.55B in top-line revenue, marking a sequential decrease of 8.6%. The company recorded net income of $2.84B, with diluted EPS of $2.38. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Financial Services. Across the four most recent quarters, SSREY averaged $1.83 in diluted EPS.
Company Profile
Swiss Re AG operates in the Insurance - Reinsurance industry within the Financial Services sector. It is headquartered in Zurich, CH. The company is led by CEO Andreas Berger. SSREY has traded publicly since 2011.
SSREY Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Global presence and strong brand reputation
- Diversified business model across multiple lines of reinsurance
- Expertise in complex risk management and modeling
- Significant capital base and financial strength
Bear Case
- Exposure to large-scale catastrophic events
- Sensitivity to fluctuations in interest rates
- Complexity of reinsurance contracts and risk modeling
- Dependence on the financial health of its clients
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $22.55B | $2.84B | $2.38 |
| Q4 FY2025 | $24.66B | $2.17B | $1.79 |
| Q2 FY2025 | $21.20B | $2.66B | $2.20 |
| Q4 FY2024 | $25.58B | $1.14B | $0.96 |
Q2 FY2026 · filed 30 Jun 2026 · Financial Modeling Prep
Based on FMP financials and quantitative analysis
SSREY Latest News
-
Swiss Re (OTCMKTS:SSREY) Stock Price Crosses Above 50-Day Moving Average – What’s Next?
defenseworld.net · Sep 3, 2026
-
Swiss Re: Higher Earnings Visibility Supports Further Upside
seekingalpha.com · Sep 1, 2026
-
3 Insurers to Focus on as Insurance Pricing Momentum Moderates
Yahoo! Finance: SSREY News · Aug 25, 2026
-
Swiss Re Ltd. (OTCMKTS:SSREY) Short Interest Down 42.5% in July
defenseworld.net · Aug 18, 2026
SSREY Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for SSREY.
Price Targets
Consensus target: $37.10
SSREY MoonshotScore
What does this score mean?
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. SSREY scores 50/100 (Grade B): the number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
Latest News
Swiss Re (OTCMKTS:SSREY) Stock Price Crosses Above 50-Day Moving Average – What’s Next?
Swiss Re: Higher Earnings Visibility Supports Further Upside
3 Insurers to Focus on as Insurance Pricing Momentum Moderates
Swiss Re Ltd. (OTCMKTS:SSREY) Short Interest Down 42.5% in July
Leadership: Alexander Andreas Berger
Unknown
Alexander Andreas Berger currently manages 15,000 employees at Swiss Re AG. His leadership is pivotal in guiding Swiss Re through the complexities of the global reinsurance market and ensuring the company's continued success.
Track Record: Information regarding Alexander Andreas Berger's specific achievements, strategic decisions, and company milestones under his leadership is not available in the provided data. Assessing his impact on Swiss Re's performance requires access to additional information and performance metrics.
Swiss Re AG ADR Information Unsponsored
An American Depositary Receipt (ADR) is a certificate representing shares of a foreign company trading on U.S. stock exchanges. SSREY functions as a Level 1 ADR, meaning it trades over-the-counter (OTC) without needing to meet the strict listing requirements of exchanges like the NYSE or NASDAQ. This allows U.S. investors to invest in Swiss Re AG more easily.
- Home Market Ticker: SIX Swiss Exchange, Switzerland
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: SSRE
SSREY OTC Market Information
The OTC Other tier represents the lowest tier of the over-the-counter (OTC) market. Companies in this tier often have limited financial disclosure and may not meet the minimum listing requirements of major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information, lower liquidity, and greater price volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency
- Lower liquidity and wider bid-ask spreads
- Potential for price volatility and manipulation
- Higher risk of fraud or mismanagement
- Limited regulatory oversight and investor protection
- Verify the company's registration and regulatory filings.
- Review the company's financial statements and audit reports (if available).
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and corporate governance practices.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Check for any news or regulatory actions related to the company.
- Established history as a global reinsurance company
- Presence in the financial services sector
- ADR status, indicating some level of regulatory oversight
- Operations in a regulated industry (insurance)
- Home market listing on the SIX Swiss Exchange
SSREY Financial Services Stock FAQ
What does the AI Score mean for SSREY?
SSREY holds an AI Score of 50/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. The number comes from the legacy nine-factor engine (quantitative signals from revenue growth to news sentiment), written once, not refreshed.
Is SSREY a good stock?
Stock Expert AI does not rate SSREY buy, sell or hold. Swiss Re AG carries a MoonshotScore of 50/100 on the legacy nine-factor engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
What does Swiss Re AG do?
Swiss Re AG is a leading global reinsurance company that provides a wide range of risk transfer, insurance, and related services.
What are the key factors to evaluate for SSREY?
Swiss Re AG (SSREY) holds a MoonshotScore of 50/100 (moderate). P/E: 10.09x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does SSREY data refresh on this page?
SSREY's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven SSREY's recent stock price performance?
Swiss Re AG (SSREY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global presence and strong brand reputation. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider SSREY overvalued or undervalued right now?
Swiss Re AG (SSREY) trades at 10.09x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of SSREY?
Yes, most major brokerages offer fractional shares of Swiss Re AG (SSREY) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track SSREY's earnings and financial reports?
Swiss Re AG (SSREY) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for SSREY earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data is limited; further due diligence is recommended.